CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma

Modern Pathology

Volumn 9, Issue 5, 1996, Pages 507-512

  Ohori, N Paul ^a,b   Coppola, Domenico ^a   Landreneau, Rodney J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adhesion molecule; Bronchioloalveolar carcinoma; CD44; Immunohistochemistry; Lung

Indexed keywords

CD44V ANTIGEN; HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED;

EID: 0029998420     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Clayton F: Bronchioloalveolar carcinomas. Cancer 57:1555, 1986
2. Clayton F: The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 23:361, 1988
3. Liebow AA: Bronchiolo-alveolar carcinoma. Adv Intern Med 10:329, 1960
4. Bolen JW, Throning D: Histogenetic classification of pulmonary carcinomas: Peripheral adenocarcinomas studied by light microscopy, histochemistry, and electron microscopy. Pathol Annu 17:77, 1982
5. Edwards CW: Alveolar carcinoma: A review. Thorax 39:166, 1984
6. Barsky SH, Grossman DA, Ho J, Holmes EC: The multifocality of bronchioloalveolar lung carcinoma: Evidence and implication of a multiclonal origin. Mod Pathol 7:633, 1994
7. Stamenkovic I, Aruffo A, Amiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343, 1991
8. Screaton GR, Bell MV, Jackson DG, et al.: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89:12160, 1992
9. Screaton GR, Bell MV, Bell JI, Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. J Biol Chem 17:12235, 1993
10. Gunthert U, Hofmann M, Rudy W, et al.: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13, 1991
11. Hofmann M, Rudy W, Zoller M, et al.: CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292, 1991
12. Rudy W, Hofmann M, Schwartz-Albiez R, et al.: The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: Each one individually suffices to confer metastatic behavior. Cancer Res 53:1262, 1993
13. Seiter S, Arch R, Reber S, et al.: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443, 1993
14. Heider KH, Hofmann M, Hors E, et al.: A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol 120:227, 1993
15. Heider KH, Dammrich J, Skroch-Angel P, et al.: Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197, 1993
16. Koopman G, Heider KH, Horst E, et al.: Activated human lymphocytes and aggressive Non-Hodgkin's lymphomaa express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897, 1993
17. Mastumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 2:1053, 1992
18. Brooks L, Niedobitek G, Agathanggelou A, Farrell PJ: The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. Am J Pathol 146:1102, 1995
19. Aruffo A, Stamenkovic I, Melnik M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303, 1990
20. Jalkanen S, Reichert R, Gallatin WMG, et al.: Homing receptors and the control of lymphocyte migration. Immunol Rev 91:39, 1986
21. Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC: Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85-90kd glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983, 1987
22. Wielenga VJM, Heider KH, Offerhaus JA, et al.: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754, 1993
23. Mulder JWR, Kruyt PM, Sewnath M, et al.: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 2:1470, 1994
24. Fox SB, Fawcett J, Jackson DG, et al.: Normal human tissue, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res 54:4539, 1994
25. Terpe HJ, Stark H, Prehm P, Gunthert U: CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101:79, 1994
26. Mackay CR, Terpe HJ, Stauder R, et al.: Expression and modulation of CD44 variant isoform in humans. J Cell Biol 124:71, 1994
27. Yaegashi N, Fujita N, Yajima A, Nakamura M. Menstrual cycle-dependent expression of CD44 in normal human endometrium. Hum Pathol 26:862, 1995
28. Jackson DG, Schenker T, Waibel R, Bell JI, Stahel RA: Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas. Int J Cancer 8(Suppl):110, 1994
29. Penno MB, August JT, Baylin SB, et al.: Expression of CD44 in human lung tumors. Cancer Res 54:1381, 1994
30. Coppola D, Clarke MR, Landreneau RJ, et al.: bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung. Mod Pathol 9:484, 1996